Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-243950
Filing Date
2025-10-21
Accepted
2025-10-20 20:00:48
Documents
4
Period of Report
2025-10-20

Document Format Files

Seq Description Document Type Size
1 6-K d62294d6k.htm 6-K 9740
2 EX-99.1 d62294dex991.htm EX-99.1 15292
3 GRAPHIC g62294g1020165050929.jpg GRAPHIC 3460
4 GRAPHIC g62294g1020165051023.jpg GRAPHIC 956
  Complete submission text file 0001193125-25-243950.txt   32636
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 251405162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)